Fed. Circ. Affirms Obviousness Of Merck Antibiotic Patent
The Federal Circuit in a split decision Thursday upheld a Delaware federal judge's ruling after a bench trial that a patent on Merck's antibiotic Invanz, asserted against Hospira, is invalid, saying...To view the full article, register now.
Already a subscriber? Click here to view full article